Raman Bedi joins Oragenics as senior consultant

Jan. 10, 2006
In addition, Dr. Bedi will organize and serve as chair for comanay's International Advisory Committee of experts in oral health care.

Oragenics, Inc. has announced that Dr. Raman Bedi has joined the company as senior consultant.

In addition, he has agreed to organize and chair its International Advisory Committee of world leading experts in oral health care.

Dr. Bedi became the eighth Chief Dental Officer for England in 2002, following a distinguished academic career and having been awarded the Foundation chair in Transcultural Oral Health at University College London (1996-2002).

Dr. Bedi retired from the post of Chief Dental Officer in October 2005 and is returning to his chair at Kings College London. He has published over 185 scientific papers and authored four books.

"Oragenics is honored to have someone of Dr. Bedi's stature agree to chair our Advisory Committee," said Dr. Zahradnik, Oragenics' Chief Executive Officer. "As senior consultant, Professor Bedi, will spearhead a global strategy for moving our technologies through clinical trials, partnering and commercialization."

Dr. Bedi is the past President of the British Society for Disability and Oral Health (2002), Past President of the Education Research Group of the International Association for Dental Research (IADR)(2002-2004) and past chair of the IADR Regional Development Program Committee (2002-2004).

He was a member of the NHS Top team (2002-2005) and Founder member of the National Health and Social care leadership network (2004-2005). In Higher Education, he is a Board member of the Higher Education Funding Council strategic committee on wider participation and Board member of the HE Leadership Foundation.

"These are exciting and challenging times for dentistry," stated Dr. Bedi.

"I look forward to working with Oragenics. They are an intriguing company with a portfolio of unique products, including their breakthrough technology, replacement therapy. I am ready to begin organizing and chairing the International Advisory Committee on how best new technologies can address and eradicate the commonest disease in children, namely dental caries. Oragenics has the potential to become a global player in oral health prevention."